J.P. Morgan Healthcare Conference (Actelion) - Jan 10, 2012 - Setipiprant / Actelion; Anticipated P3 profiling study for allergic rhinitis in H1 2012
Anticipated P3 study
|
|
Setipiprant
-- -- --
ANTICIPATED NEWS FLOW
H1 2012
Setipiprant in allergic rhinitis first Phase III profiling study
-- -- --
|